News All PostNewsAxxam awarded with EUR 0.5 million by the Lombardy Region to support a innovative high throughput method for early “in…23 October 2011read more >Fast Forward, Juvenile Diabetes Research Foundation and Axxam SpA Renew their Partnership to Accelerate Development of Treatments for Multiple Sclerosis…16 September 2011read more >Axxam and Polyphor Participate in a Research Partnership for the Treatment of Type-2 Diabetes Funded by the EU18 July 2011read more >Axxam SpA receives funding for the development of compounds for prevention treatment of disability in Multiple Sclerosis12 July 2011read more >Axxam awarded a Research Grant by the Alzheimer’s Drug Discovery Foundation to develop Novel Therapeutics for Alzheimer’s Disease16 June 2011read more >Axxam SpA is happy to announce the foundation and establishment of IMAX Discovery GmbH (IMAX)5 May 2011read more >Load MoreEnd of Content.
Axxam awarded with EUR 0.5 million by the Lombardy Region to support a innovative high throughput method for early “in…23 October 2011read more >
Fast Forward, Juvenile Diabetes Research Foundation and Axxam SpA Renew their Partnership to Accelerate Development of Treatments for Multiple Sclerosis…16 September 2011read more >
Axxam and Polyphor Participate in a Research Partnership for the Treatment of Type-2 Diabetes Funded by the EU18 July 2011read more >
Axxam SpA receives funding for the development of compounds for prevention treatment of disability in Multiple Sclerosis12 July 2011read more >
Axxam awarded a Research Grant by the Alzheimer’s Drug Discovery Foundation to develop Novel Therapeutics for Alzheimer’s Disease16 June 2011read more >
Axxam SpA is happy to announce the foundation and establishment of IMAX Discovery GmbH (IMAX)5 May 2011read more >